Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response

Ratnoff, 1961, Studies on the action of Hageman factor: Evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent, J. Clin. Invest, 40, 803, 10.1172/JCI104314 Kaplan, 1970, A prealbumin activator of prekallikrein, J. Immunol, 105, 802, 10.4049/jimmunol.105.4.802 Kaplan, 1972, The fibrinolytic pathway of human plasma, J. Exp. Med, 136, 1378, 10.1084/jem.136.6.1378 Webster, 1961, Role of Hageman factor in the activation of vasodilator activity in human plasma, Nature, 192, 180, 10.1038/192180a0 Kaplan, 1972, A prealbumin activator of prekallikrein. III. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein, J. Exp. Med, 135, 81, 10.1084/jem.135.1.81 Kaplan, 1973, The fibrinolytic pathway of human plasma. II. Generation of chemotactic activity by activation of plasminogen proactivator, J. Clin. Invest, 52, 2591, 10.1172/JCI107451 Cochrane, 1973, Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein, J. Exp. Med, 138, 1564, 10.1084/jem.138.6.1564 Weiss, 1974, Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity and kinin generation, J. Clin. Invest, 53, 622, 10.1172/JCI107597 Kaplan, 1971, A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin, J. Exp. Med, 133, 696, 10.1084/jem.133.4.696 Cochrane, 1972, The structure and activation of Hageman factor, 119 Saito, 1974, Inhibition of the adsorption of Hageman factor (factor XII) to glass by normal human plasma, J. Lab. Clin. Med, 84, 62 Niewiarowski, 1965, Studies in the adsorption and activation of the Hageman factor (factor XII) by collagen and elastin, Thromb. Diath. Haemorrh, 14, 387, 10.1055/s-0038-1654877 Wilner, 1968, Activation of Hageman factor by collagen, J. Clin. Invest, 47, 2608, 10.1172/JCI105943 Morrison, 1974, Direct evidence for Hageman factor (Factor XII) activation by bacterial lipopolysaccharides (endotoxin), J. Exp. Med, 140, 797, 10.1084/jem.140.3.797 Kellermeyer, 1965, The inflammatory process in acute gouty arthritis. I. Activation of Hageman factor by sodium urate crystals, J. Lab. Clin. Med, 65, 307 Ratnoff, 1968, Activation of Hageman factor by l-homocysteine, Science, 29, 1007, 10.1126/science.162.3857.1007-a Hathaway, 1965, Evidence of a new plasma thromboplastin factor I. Case report, coagulation studies and physicochemical properties, Br. J. Hematol, 26, 521 Hathaway, 1970, The relation of “Fletcher factor” to factors XI and XII, Br. J. Haematol, 18, 161, 10.1111/j.1365-2141.1970.tb01431.x Wuepper, 1973, Prekallikrein deficiency in man, J. Exp. Med, 138, 1345, 10.1084/jem.138.6.1345 Kaplan, 1971, The bradykinin forming system of man, 280 Spragg, 1973, The use of isoelectric focusing to study components of the human plasma kinin-forming system, Ann. N. Y. Acad. Sci, 209, 372, 10.1111/j.1749-6632.1973.tb47541.x Cochrane, 1971, The first component of the kinin-forming system in human and rabbit plasma: Its relationship to clotting factor XII (Hageman factor), J. Exp. Med, 134, 986, 10.1084/jem.134.4.986 Wuepper, 1970, Plasma kinin system: Proenzyme components, J. Immunol, 105, 1307, 10.4049/jimmunol.105.5.1307 Treolar, 1970, Isolation of two small molecular weight activators of the plasma kinin system in the guinea pig, 29, 576 Movat, 1971, The kinin system of human plasma. I. Isolation of a low molecular weight activator of prekallikrein, Int. Arch. Allergy Appl. Immunol, 40, 89, 10.1159/000230397 Wuepper, 1971, Isolation and mechanism of activation of components of the plasma kinin-forming system, 299 Cochrane, 1971, The first component of the kinin-forming system in human and rabbit plasma: Its relationship to clotting factor XII (Hageman factor), J. Exp. Med, 134, 986, 10.1084/jem.134.4.986 Soltay, 1972, The kinin system of human plasma. V. The probable derivation of prekallikrein activator from activated Hageman factor, 138, 952 Mackay, 1953, Susceptibility of the guinea pig to pharmacological factors from its own serum, Nature (Lond.), 172, 714, 10.1038/172714b0 Stewart, 1957, The permeability-increasing factor in diluted human plasma, Br. J. Exp. Pathol, 38, 462 Webster, 1969, The kinin system—a review, 207 Lawrence, 1970, Activation of prokininogenase activator (PKA) by clot promoting factor (CPF) in rabbit plasma, 29, 576 Johnston, 1974, The relationship between PF/dil and activated human Hageman factor, J. Immunol, 113, 103, 10.4049/jimmunol.113.1.103 Heck, 1974, Substrates of Hageman factor. I. Isolation and characterization of human Factor XI (PTA) and inhibition of the activated enzyme by α1 antitrypsin, J. Exp. Med, 140, 1615, 10.1084/jem.140.6.1615 Wuepper, 1972, Biochemistry and biology of the components of the plasma kinin-forming system Kaplan, A. P.: Unpublished observations. Colman, 1969, Studies on the prekallikrein (kallikreinogen)-kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein, J. Clin. Invest, 48, 23, 10.1172/JCI105971 Kagen, 1964, Some biochemical and physical properties of the human permeability globulins, Br. J. Exp. Pathol, 45, 604 Kagen, 1963, The presence of two permeability globulins in human serum, Nature (Lond.), 197, 693, 10.1038/197693a0 Webster, 1963, The nature of the kallidins released from human plasma by kallikrein and other enzymes, Ann. N. Y. Acad. Sci, 104, 41 Takahashi, 1972, Conversion of bovine prekallikrein to kallikrein. Evidence of limited proteolysis of prekallikrein by bovine Hageman factor (factor XII), FEBS Lett, 24, 98, 10.1016/0014-5793(72)80835-4 Wuepper, 1972, Plasma prekallikrein: Isolation, characterization, and mechanism of activation, J. Exp. Med, 135, 1, 10.1084/jem.135.1.1 Laake, 1974, Factor XII-induced fibrinolysis: Studies on the separation of prekallikrein, plasminogen proactivator and factor XI in human plasma, Thromb. Res, 4, 285, 10.1016/0049-3848(74)90093-0 Rapaport, 1963, The importance of activation of antihemophilic globulin and pro-accelerin by traces of thrombin in the generation of intrinsic prothrombinase activity, Blood, 21, 221, 10.1182/blood.V21.2.221.221 Lorand, 1962, Activation of fibrin stabilizing factor by thrombin, 21, 62 Quick, 1952, The Mechanism of clot retraction, Science, 112, 558, 10.1126/science.112.2915.558 Marcus, 1964, Studies on subcellular platelet particles, Blood, 23, 389, 10.1182/blood.V23.3.389.389 Osterud, 1970, Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VII and to factor IX, 9, 1854 Colman, 1970, Factor V: An activator of factor Xa in the absence of prothrombin, Br. J. Haematol, 19, 675, 10.1111/j.1365-2141.1970.tb07012.x Nilsson, 1957, On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time, Acta. Med. Scand, 159, 35, 10.1111/j.0954-6820.1957.tb00532.x Owen, 1972, Antihemophilic factor: Separation of an active fragment following dissociation by salts or detergents, Thromb. Diath. Haemorrh, 27, 502, 10.1055/s-0038-1649389 Weiss, 1972, Separation of subunits of antihemophilic factor (AHG) by agarose gel chromatography, Thromb. Diath. Haemorrh, 27, 212, 10.1055/s-0038-1649358 Weiss, 1973, Von Willebrand factor: Dissociation from antihemophilic factor procoagulant activity, Science, 182, 1149, 10.1126/science.182.4117.1149 Zimmerman, 1973, Factor VIII coagulant activity and factor VIII-like antigen: Independent molecular entities, J. Exp. Med, 138, 1015, 10.1084/jem.138.4.1015 Hougie, 1973, Antigen/biological activity ratio for factor VIII, Lancet, 1, 616, 10.1016/S0140-6736(73)90773-3 Reddy, 1971, Mechanism of activation of human plasminogen by streptokinase. Presence of an active center in streptokinase-plasminogen complex, J. Biol. Chem, 247, 1683, 10.1016/S0021-9258(19)45531-2 Reddy, 1973, Further evidence for an active center in streptokinase-plasminogen complex: Interaction with pancreatic trypsin inhibitor, Biochem. Biophys. Res. Commun, 51, 672, 10.1016/0006-291X(73)91367-3 Schick, 1974, Direct evidence for the generation of an active site in the plasminogen moiety of the streptokinase-human plasminogen activator complex, Biochem. Biophys. Res. Commun, 57, 47, 10.1016/S0006-291X(74)80355-4 De Renzo, 1967, Interaction of streptokinase and human plasminogen. IV. Further gel electrophoretic studies on the combination of streptokinase with human plasminogen or human plasmin, J. Biol. Chem, 242, 2428, 10.1016/S0021-9258(18)95979-X Summaria, 1968, The active site of bovine plasminogen activator. Interaction of streptokinase with human plasminogen and plasmin, J. Biol. Chem, 243, 144, 10.1016/S0021-9258(18)99335-X Robbins, 1967, The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin, J. Biol. Chem, 242, 2333, 10.1016/S0021-9258(18)95967-3 Barlow, 1969, Molecular weight studies on human plasminogen and plasmin at the microgram level, J. Biol. Chem, 244, 1138, 10.1016/S0021-9258(18)91819-3 Taylor, 1968, Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen, Biochemistry, 7, 232, 10.1021/bi00841a028 Wiman, 1973, Activation of human plasminogen by an insoluble derivative of urokinase—structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound, Eur. J. Biochem, 36, 25, 10.1111/j.1432-1033.1973.tb02880.x Wiman, 1963, Primary structure of peptides released during activation of human plasminogen by urokinase, Eur. J. Biochem, 39, 1, 10.1111/j.1432-1033.1973.tb03096.x Robbins, 1966, An immunochemical study of human plasminogen and plasmin, Immunochemistry, 3, 29, 10.1016/0019-2791(66)90279-5 Magoon, 1974, Immunoelectrophoretic analysis and radial immunodiffusion assay using plasminogen purified from fresh human plasma, Clin. Exp. Immunol, 17, 345 Summaria, 1971, Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods, J. Biol. Chem, 247, 4691, 10.1016/S0021-9258(19)45042-4 Spragg, 1971, The preparation of human kininogen. II. Further characterization of purified human kininogen, J. Immunol, 107, 1512, 10.4049/jimmunol.107.6.1512 Spragg, 1974, Preparation of human kininogen. III. Enzymatic digestion and modification, Biochem. Pharmacol, 23, 781, 10.1016/0006-2952(74)90208-1 Brocklehurst, 1966, The purification of a kininogen from human plasma, Br. J. Pharmacol, 27, 256 Jacobsen, 1967, Some data on two purified kininogens from human plasma, Br. J. Pharmacol, 29, 25 Kato, 1967, Physicochemical properties of bovine kininogen. II, J. Biochem, 62, 591, 10.1093/oxfordjournals.jbchem.a128709 Yano, 1967, Separation of a new substrate, kininogen-I, for plasma kallikrein in bovine plasma, J. Biochem, 62, 504, 10.1093/oxfordjournals.jbchem.a128698 Pierce, 1968, Structural features of plasma kinins and kininogens, 27, 52 Habal, 1974, Kininogens of human plasma, 33, 641 Yans, 1970, Evidence for the location of methionyl-lysyl-bradykinin moieties at the carboxyl terminus and inside of bovine kininogen. I, Biochem. Biophys. Res. Commun, 40, 914, 10.1016/0006-291X(70)90990-3 Nagagawa, 1966, Studies on the chemical nature of bovine bradykininogen: Determinations of amino acid, carbohydrate, amino and carboxyl terminal residues, J. Biochem, 60, 643, 10.1093/oxfordjournals.jbchem.a128490 Kato, 1968, The location and nature of the linkage of kinin moiety in bovine kininogen. II, Biochem. Biophys. Res. Commun, 32, 800, 10.1016/0006-291X(68)90311-2 Forbes, 1970, Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified Cl̄ inactivator, J. Lab. Clin. Med, 76, 809 Schreiber, 1973, Inhibition by Cl̄ INH of Hageman factor fragment activation of coagulation, fibrinolysis, and kinin generation, J. Clin. Invest, 52, 1402, 10.1172/JCI107313 Damus, 1973, Anticoagulant action of heparin, Nature (Lond.), 246, 355, 10.1038/246355a0 Schreiber, 1973, Plasma inhibitors of the components of the fibrinolytic pathway in man, J. Clin. Invest, 52, 1394, 10.1172/JCI107312 Goetzl, 1974, Active site chemotactic factors and the regulation of the human neutrophil chemotactic response, 218, 10.1159/000395433 Gigli, 1970, Interaction of plasma kallikrein with Cl̄ inhibitor, J. Immunol, 104, 574, 10.4049/jimmunol.104.3.574 Harpel, 1970, Human plasma α2-macroglobulin. An inhibitor of plasma kallikrein, J. Exp. Med, 132, 329, 10.1084/jem.132.2.329 Lahiri, 1974, Antithrombin III: An inhibition of human plasma kallikrein, 33, 642 Highsmith, 1974, The inhibition of human plasmin by human antithrombin-heparin cofactor, J. Biol. Chem, 249, 4335, 10.1016/S0021-9258(19)42424-1 Abildgaard, 1967, Purification of two progressive antithrombins of human plasma, Scand. J. Clin. Lab. Invest, 19, 190, 10.3109/00365516709093501 Abildgaard, 1969, Binding of thrombin to antithrombin III, Scand. J. Clin. Lab. Invest, 24, 23, 10.3109/00365516909080127 Rosenberg, 1973, Purification and mechanism of action of human antithrombin-heparin cofactor, J. Biol. Chem, 248, 6490, 10.1016/S0021-9258(19)43472-8 Yin, 1971, Identity of plasma-activated factor X inhibitor with antithrombin III and heparin cofactor, J. Biol. Chem, 246, 3712, 10.1016/S0021-9258(18)62185-4 Marciniak, 1973, Factor Xa inactivation by antithrombin III: Evidence for a biological stabilization of factor Xa by factor V—Phospholipid complex, Br. J. Haematol, 24, 391, 10.1111/j.1365-2141.1973.tb01662.x Rimon, 1966, Plasma inhibitor of human plasma IV. Its action on plasmin, trypsin, chymotrypsin and thrombin, J. Biol. Chem, 241, 5102, 10.1016/S0021-9258(18)99676-6 Erdos, 1962, An enzyme in human blood plasma that inactivates bradykinin and kallidins, Biochem. Pharmacol, 11, 585, 10.1016/0006-2952(62)90119-3 Bokisch, 1970, Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase, J. Clin. Invest, 49, 2427, 10.1172/JCI106462 Erdos, 1967, Second kininase in human blood plasma, Nature, 215, 1402, 10.1038/2151402a0 Ozawa, 1966, The reactive site of trypsin inhibitors, J. Biol. Chem, 241, 3955, 10.1016/S0021-9258(18)99798-X Krahn, 1973, Peptide-bond hydrolysis equilibria in the antitrypsin site of lima bean trypsin inhibitor, Biochemistry, 12, 1330, 10.1021/bi00731a600 Harpel, 1973, Degradation of human fibrinogen by plasma α2-macroglobulin-enzyme complexes, J. Clin. Invest, 52, 2175, 10.1172/JCI107402 Soter, 1974, The complement system in necrotizing angiitis of the skin. Analysis of complement component activities in serum of patients with concomitant collagen-vascular disease, J. Invest. Dermatol, 63, 219, 10.1111/1523-1747.ep12679439 Gotze, 1971, The C3 activator system: An alternate pathway of complement activation, J. Exp. Med, 134, 90, 10.1084/jem.134.3.90 Platts-Mills, 1974, Activation of the alternate pathway of human complement by rabbit cells, J. Immunol, 113, 348, 10.4049/jimmunol.113.1.348 Davies, 1962, Further studies on a permeability factor released from guinea pig serum by antigen antibody precipitates: Relationship to serum complement, Int. Arch. Allergy Appl. Immunol, 20, 235, 10.1159/000229263 Eisen, 1970, Plasma kinin formation by complexes of aggregated γ-globulins and serum proteins, Br. J. Exp. Pathol, 51, 328 Epstein, 1969, Rheumatoid factor and kinin generation, Ann. N. Y. Acad. Sci, 168, 173, 10.1111/j.1749-6632.1969.tb43106.x Movat, 1969, A small molecular weight-permeability factor in guinea-pig serum: Adsorption to antigen-antibody aggregates, J. Immunol, 103, 875, 10.4049/jimmunol.103.4.875 Cochrane, 1970, The kinin forming system: Delineation and activation, 220 Yonemasu, 1971, Chemical studies in C1q: A modulator of immunoglobulin biology, Biochem. Biophys. Res. Commun, 43, 1388, 10.1016/S0006-291X(71)80028-1 Cochrane, 1972, The interaction of Hageman factor and immune complexes, J. Clin. Invest, 51, 2736, 10.1172/JCI107093 Rocha e Silva, 1972, The kinin trail: Possible significance of bradykinin and kinin to autopharmacology, Vol. 5, 250 Gladner, 1963, The nature of peptides released by thrombin, Ann. N. Y. Acad. Sci, 104, 47, 10.1111/j.1749-6632.1963.tb17651.x Kay, 1973, Generation of chemotactic activity for leucocytes by the action of thrombin on human fibrinogen, Nature [New Biol.], 243, 56 Gallin, 1974, Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by Cl̄ inhibitor and α2 macroglobulin, J. Immunol, 113, 1928, 10.4049/jimmunol.113.6.1928 Goetzl, 1974, Stimulation of human neutrophil leucocyte aerobic glucose metabolism by purified chemotactic factors, J. Clin. Invest, 53, 591, 10.1172/JCI107594 Ratnoff, 1967, The conversion of C′1S to C′1 esterase by plasmin and trypsin, J. Exp. Med, 125, 337, 10.1084/jem.125.2.337 Ward, 1967, A plasmin-split fragment of C3 as a new chemotactic factor, J. Exp. Med, 126, 189, 10.1084/jem.126.2.189 Muller-Eberhard, 1972, C3 proactivator convertase and its mode of action, J. Exp. Med, 135, 1003, 10.1084/jem.135.4.1003 Gigli, 1971, Modulation of the function of the activated first component of complement by a fragment derived from serum. I. Effect on early components of complement, J. Exp. Med, 134, 1466, 10.1084/jem.134.6.1466 Taylor, 1970, Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets, J. Clin. Invest, 49, 2068, 10.1172/JCI106425 Astrup, 1974, A plasminogen proactivator-activator system in human blood effective in absence of Hageman factor, Thromb. Res, 4, 609, 10.1016/0049-3848(74)90235-7 Schreiber, 1974, Hageman factor independent fibrinolytic pathway, Clin. Exp. Immunol, 17, 603 Colman, R. W., Bagdasarian, A., Talamo, R. C., and Kaplan, A. P.: Combined deficiency of plasma plasminogen proactivator and kininogen, in Pisano, J., and Austen, K. F., editors: The kallikrein-kinin system in health and disease, Fogarty International Center Proceedings No. 27, Washington, D. C., U. S. Government Printing Office. In press. Colman, R. W., Bagdasarian, A., Talamo, R. C., Scott, C. F., Seavey, M., Guimaraes, J. A., Pierce, J. V., and Kaplan, A. P.: Williams trait: Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. In press, J. Clin. Invest. Saito, 1975, Fitzgerald trait: Deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface-mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability (PF/dil), J. Clin. Invest, 55, 1082, 10.1172/JCI108009 Wuepper, 1975, Flaujaec trait: Deficiency of kininogen in man, 34, 859